Michael Ryskin
Stock Analyst at B of A Securities
(1.41)
# 3,591
Out of 5,149 analysts
41
Total ratings
50%
Success rate
-2.67%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Maintains: Neutral | $7 → $6 | $3.54 | +69.49% | 3 | Feb 26, 2026 | |
| ZTS Zoetis | Maintains: Neutral | $135 → $140 | $125.93 | +11.17% | 8 | Feb 13, 2026 | |
| SDGR Schrödinger | Upgrades: Buy | $24 | $12.50 | +92.00% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $95.95 | +3.18% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $51.40 | +36.19% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $635.54 | -25.26% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.69 | +116.80% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $182.64 | +12.79% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $93.30 | -57.13% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $0.88 | +978.81% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $7.24 | +231.49% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $8.78 | +173.35% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $2.57 | +289.11% | 2 | Nov 10, 2021 |
Recursion Pharmaceuticals
Feb 26, 2026
Maintains: Neutral
Price Target: $7 → $6
Current: $3.54
Upside: +69.49%
Zoetis
Feb 13, 2026
Maintains: Neutral
Price Target: $135 → $140
Current: $125.93
Upside: +11.17%
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $12.50
Upside: +92.00%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $95.95
Upside: +3.18%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $51.40
Upside: +36.19%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $635.54
Upside: -25.26%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.69
Upside: +116.80%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $182.64
Upside: +12.79%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $93.30
Upside: -57.13%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $0.88
Upside: +978.81%
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $7.24
Upside: +231.49%
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $8.78
Upside: +173.35%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $2.57
Upside: +289.11%